Decreased tissue reaction to bioprosthetic heart valve material after L-glutamic acid treatment. A morphological study.

Degenerative alterations of two different glutaraldehyde (GA)-fixed bioprosthetic heart valve materials were investigated in subcutaneous rat implants: Bovine pericardium, prepared according to clinically used bioprosthetic heart valve material (BHV) was compared to alternatively preserved pericardium (APHV), which was fixed in GA and treated with L-glutamic acid. Following 63 days of subcutaneous implantation, calcification of APHV implants was significantly lower as compared to BHV implants (13 +/- 6 versus 158 +/- 18 micrograms Ca/mg dry weight tissue; p less than 0.05). In BHV implants ultrastructural investigations showed nucleation of plate-shaped hydroxyapatite crystals at the surface of collagen fibrils and in remnants of connective tissue cells; no signs of calcification could be detected in APHV implants. The time-course of the inflammatory reaction was determined by quantification of immunohistochemical stained mononuclear host-cells invading the implants. In both preparation groups inflammatory reaction reached maximum 42 days after implantation. However, infiltration rate of inflammatory cells was markedly decreased in APHVs as compared to BHVs (p less than 0.05).

[1]  W. Roberts,et al.  Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves. Transmission and scanning electron microscopic observations in 12 patients. , 1978, The American journal of cardiology.

[2]  D. Cooley,et al.  Early experience with the ionescu-shiley pericardial xenograft valve. Accelerated calcification in children. , 1983, The Journal of thoracic and cardiovascular surgery.

[3]  M E Nimni,et al.  Toxic reactions evoked by glutaraldehyde-fixed pericardium and cardiac valve tissue bioprosthesis. , 1984, Journal of biomedical materials research.

[4]  J. T. Peeler,et al.  Levels of antimony, cadmium, chromium, cobalt, manganese, and zinc in institutional total diets , 1971 .

[5]  H. Plenk,et al.  New aspects of the degeneration of bioprosthetic heart valves after long-term implantation. , 1992, The Journal of thoracic and cardiovascular surgery.

[6]  A. Carpentier,et al.  Calcifications of cardiac valve bioprostheses. Biochemical, histologic, and ultrastructural observations in a subcutaneous implantation model system. , 1982, The Journal of thoracic and cardiovascular surgery.

[7]  J. McPherson,et al.  An examination of the biologic response to injectable, glutaraldehyde cross-linked collagen implants. , 1986, Journal of biomedical materials research.

[8]  S. Weiner,et al.  Three-dimensional ordered distribution of crystals in turkey tendon collagen fibers. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Weiner,et al.  Organization of hydroxyapatite crystals within collagen fibrils , 1986, FEBS letters.

[10]  E Wolner,et al.  Toxic effects of aldehydes released from fixed pericardium on bovine aortic endothelial cells. , 1989, Journal of biomedical materials research.

[11]  R. Levy,et al.  The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. , 1987, The American journal of pathology.

[12]  E. Arbustini,et al.  Calcific degeneration as the main cause of porcine bioprosthetic valve failure. , 1984, The American journal of cardiology.

[13]  E. Wolner,et al.  Glutaraldehyde affects biocompatibility of bioprosthetic heart valves. , 1992, Surgery.

[14]  F J Schoen,et al.  Calcification of subcutaneously implanted type I collagen sponges. Effects of formaldehyde and glutaraldehyde pretreatments. , 1986, The American journal of pathology.

[15]  M Jones,et al.  Calcific deposits in porcine bioprostheses: structure and pathogenesis. , 1980, The American journal of cardiology.

[16]  D. Speer,et al.  Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials. , 1980, Journal of biomedical materials research.

[17]  F J Schoen,et al.  Bioprosthetic heart valve failure: pathology and pathogenesis. , 1984, Cardiology clinics.